Australian biotech companies: Navigating the maze

Journal of Commercial Biotechnology

Volumn 11, Issue 2, 2005, Pages 111-120

  Herpin, Timothy F ^a   Karuso, Helen ^b,c   Foley, James E ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b Australian Govt Trade Agy Astrade   (United States)

^c Embassy of Australia   (United States)

Author keywords

Australia; Biotechnology; Business model; Government incentives; Life sciences

Indexed keywords

BIOMEDICAL EQUIPMENT; DRUG PRODUCTS; INDUSTRIAL MANAGEMENT; INVESTMENTS; PROJECT MANAGEMENT; RISK MANAGEMENT; STRATEGIC PLANNING;

BIOTECHNOLOGY INDUSTRY; FUNDS; PARTNERSHIPS; RISK DEVELOPMENT;

BIOTECHNOLOGY;

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; ANTIOBESITY AGENT; ANTIVIRUS AGENT; AOD 9604; CANCER VACCINE; CHAPERONIN; CLIOQUINOL; MANNITOL; NARDG 35; NORADRENALIN TRANSPORTER; NV 06; OPIATE; PBT 1; PENTRYS; PEP 005; PHENOXODIOL; PI 166; PI 88; PROTEIN KINASE C INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE INHIBITOR; Q 8003; SBP 002; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE; VENOM ANTISERUM; VIRUS VACCINE; VIVAGEL; XEN 2174;

ARTICLE; AUSTRALIA; BIOTECHNOLOGY; CLINICAL STUDY; CLINICAL TRIAL; DEVICE; DRUG DELIVERY SYSTEM; DRUG RESEARCH; FINANCIAL MANAGEMENT; GOVERNMENT; HUMAN; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; POWDER INHALER; QUALITY CONTROL;

EID: 14044256591     PISSN: 14628732     EISSN: None     Source Type: Journal    
DOI: 10.1057/palgrave.jcb.3040108     Document Type: Article

References (10)

1. Global Partners, 'Australian Biotechnology 2004', Australian Government Report from Department of Industry, Tourism and Resources, Commonwealth of Australia/Advance Consulting of Evaluation Pty Ltd/Aoris Nova.
2. Ernst & Young (2001), 'Australian Biotechnology Report 2001', Paragon Printers, Canberra.
3. URL: http://www.the-funneled-web.com/
4. URL: http://grants1.nih.gov/grants/
5. Karuso, H. and Ogilvie, B. (2003), 'Report on Accessing Grant Funding through the US for Australian Life Sciences Research', Austrade/New Zealand Trade Development Board.
6. Australian Government Programs (URL: http://www.ausindustry.gov.au).
7. Sparling, D. and Vitale, M., 'Australian Biotechnology Do Perceptions and Reality Meet? Report on ASX Biotechnology IPOs 1998-2002', University of New South Wales, Sydney.
8. Buckley, C. (2004), 'Biotech business down under', Nature Vol. 429, pp. 5-9.
9. 'Biotechs are back with a vengeance' (2004) (URL: http://www.theage.com.au).
10. Directory of Australian Biotechnology Companies (URL: http://www.ausbiotech.org).